choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Biotechnology Drugs

Biotechnology Drugs Newsletter
  • Can AI Make Israel the World’s Next Biotech Superpower? 09 Jul 2025 20:28 GMT

    … with AI-driven biotech innovation aimed at revolutionizing drug development Just weeks … target combinations for multispecific biologic drugs—treatments designed to act … complicated than developing single-target drugs. Traditional discovery methods rely …

  • Biotech Hits Record High On 'Impressive' Results In Obesity Treatment 09 Jul 2025 23:49 GMT

    … in a public offering. The biotech company is hoping to treat … NOW PLAYING The Weight-Loss Drug Market Is Hot. Which Medical … shows up with Imcivree, another drug from Rhythm that treats other … and Rhythm's new drug, bivamelagon, impact a receptor called …

  • More Chinese ADCs enter the clinic as biotech race heats up 09 Jul 2025 23:35 GMT

    China has proved to be a fertile ground for innovation as evidenced by some big deals in the antibody-drug conjugate (ADC) space, and the number of candidates entering clinical trials in China or being advanced in the U.S. by Chinese companies. BioWorld …

  • JACKSON HEWETT: Australia’s biotech industry pops chill pill following Trump tariff scare 09 Jul 2025 22:55 GMT

    … and pharmaceutical ingredients, including finished drug products, medical countermeasures, critical … export in Australia. “Australian biotechnology and medical technology companies compete … device companies rather than drug manufacturers. Other companies were …

  • Merck to buy Verona and its lung drug in $10B deal 09 Jul 2025 20:27 GMT

    … potential multibillion-dollar new drug to treat chronic obstructive … Wednesday. The Food and Drug Administration approved Verona’s … investors, Merck said the drug strengthens its growing cardio- … -biggest acquisition of a biotechnology company this year, after …

  • Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering 09 Jul 2025 21:15 GMT

    … registered direct offering for Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT … Biotechnology Holdings, Inc., a clinical-stage pharmaceutical company focused on cancer drug … .com. About Lixte Biotechnology Holdings, Inc. Lixte Biotechnology Holdings, Inc. is …

  • Biotech firm Verona snapped up by Merck in $10bn deal 09 Jul 2025 19:33 GMT

    A London-based biotech company created by British … , a respiratory drugs company with a potential blockbuster drug, comes five … from Aim in 2020. The drug, Ohtuvayre, a potential blockbuster, … it’s a bi-functional drug.” David Zaccardelli, chief executive …

  • Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade 09 Jul 2025 17:58 GMT

    … worth of pharmaceuticals and biotech M&A deals … 11.5 popular billion obesity drug (excluding Wegovy debt) 2023 … on rare-disease and immunology drugs 2020 Bristol MyoKardia About … billion acquires blockbuster prostate cancer drug Xtandi 2015 Shire Baxalta …

  • Merck nears $10 billion deal for biotech Verona 09 Jul 2025 17:56 GMT

    … leaned on its blockbuster cancer drug Keytruda, which generated nearly … talks to buy Swiss biotech MoonLake Immunotherapeutics for more … for a heart disease drug with Jiangsu Hengrui Pharmaceuticals. … international launch of the drug in countries outside the …

  • Stocks Shrug Off Trump's Threat To Slam Drugs With Tariffs 09 Jul 2025 14:55 GMT

    … the airways. ↑ X NOW PLAYING Biotech';s Next Boom? Inside … .71. Verona's drug works differently from Regeneron Pharmaceuticals… . Dupixent is an injected drug that blocks an inflammatory cytokine … To 200% Tariffs On Drug Imports. The Market Doesn…

Satisfied with the content?

Continue to create your account.